carbitol has been researched along with Acute Myelogenous Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Briot, T; Clavreul, A; Lagarce, F; Lautram, N; Roger, E; Verger, A | 1 |
1 other study(ies) available for carbitol and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Development and in vitro evaluations of new decitabine nanocarriers for the treatment of acute myeloid leukemia.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Azacitidine; Biological Availability; Caco-2 Cells; Cell Line, Tumor; Decitabine; Drug Carriers; Drug Liberation; Drug Resistance, Neoplasm; Drug Stability; Ethylene Glycols; Humans; Leukemia, Myeloid, Acute; Lipids; Nanocapsules; Polysorbates | 2017 |